Details for Patent: 4,303,651

Summary for Patent: 4,303,651

Title:	Heparin fragments having selective anticoagulation activity
Abstract:	Heparin fragments having selective anticoagulation activity having 14-18 sugar units, the disaccharide unit L-iduronosyl-2-O-sulphate-N-sulpho-U-glucosamine-6-O-sulphate being the main component, and where unsulphated L-iduronic acid is in a position situated 3-5 sugar units from the unreducing terminal. Pharmaceutical compositions containing such heparin fragments. Processes for the preparation of the heparin fragments.
Inventor(s):	Lindahl; Ulf P. F. (Uppsala, SE), Backstrom; Gudrun E. (Alunda, SE), Thunberg; John Y. L. (Uppsala, SE), Fransson; Lars-Ake (Lund, SE), Andersson; Lars-Olov (Knivsta, SE), Holmer; Erik Y. (Bromma, SE), Sandberg; Inga H. (Sollentuna, SE), Soderstrom; Ewa G. (Saltsjobaden, SE)
Assignee:	Kabi AB (Stockholm, SE)
Application Number:	06/109,936
Patent Claim Types: see list of patent claims	Compound; Use; Composition;

Drugs Protected by US Patent 4,303,651

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 4,303,651

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	7900164	Jan 08, 1979

International Family Members for US Patent 4,303,651

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	8998
Canada	1136620
Germany	3068924
Denmark	160764